CN Stock MarketDetailed Quotes

Hefei Lifeon Pharmaceutical (003020)

Watchlist
  • 23.52
  • -0.03-0.13%
Not Open Apr 24 15:00 CST
4.47BMarket Cap27.51P/E (TTM)

Hefei Lifeon Pharmaceutical (003020) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
Total operating revenue
-3.95%1.08B
-4.80%732.44M
7.98%360.23M
-20.11%1.52B
-26.20%1.13B
-39.32%769.33M
-58.90%333.62M
-26.31%1.9B
-19.52%1.52B
3.14%1.27B
Operating revenue
-3.95%1.08B
-4.80%732.44M
7.98%360.23M
-20.11%1.52B
-26.20%1.13B
-39.32%769.33M
-58.90%333.62M
-26.31%1.9B
-19.52%1.52B
3.14%1.27B
Other operating revenue
----
55.83%18.33M
----
112.79%30.32M
----
92.44%11.77M
----
60.75%14.25M
----
75.17%6.11M
Total operating cost
-2.16%979.33M
-3.25%660.11M
5.19%323.75M
-19.41%1.36B
-26.27%1B
-39.88%682.32M
-57.86%307.76M
-29.21%1.68B
-21.69%1.36B
1.23%1.13B
Operating cost
13.16%382.96M
19.54%261.87M
28.42%132.78M
-49.22%468.29M
-58.50%338.42M
-69.65%219.06M
-79.93%103.4M
-42.90%922.2M
-29.85%815.4M
-3.32%721.72M
Operating tax surcharges
5.27%17.54M
-8.39%10.69M
14.46%5.5M
22.34%22.43M
30.15%16.66M
16.91%11.67M
-15.14%4.8M
14.90%18.34M
6.89%12.8M
25.29%9.98M
Operating expense
-13.24%458.55M
-18.37%302.49M
-4.83%150.76M
15.65%692.13M
23.87%528.54M
11.67%370.54M
-13.61%158.41M
-2.91%598.45M
-8.77%426.7M
7.20%331.81M
Administration expense
-23.51%48.88M
-25.71%33.3M
-12.14%15.86M
31.64%81.56M
37.25%63.91M
44.25%44.82M
19.01%18.05M
4.76%61.96M
17.64%46.56M
20.82%31.07M
Financial expense
198.13%365.97K
111.60%59.28K
48.85%-225.56K
93.13%-226.27K
90.11%-372.94K
78.70%-510.91K
71.63%-440.98K
7.13%-3.29M
-916.36%-3.77M
-1,082.64%-2.4M
-Interest expense (Financial expense)
16.98%1.08M
68.35%1.4M
14.75%264.36K
49.89%1.92M
73.96%926.62K
-33.14%832.41K
106.40%230.38K
43.93%1.28M
254.87%532.67K
93.44%1.25M
-Interest Income (Financial expense)
22.91%-1.28M
-3.35%-1.42M
32.49%-577.33K
52.22%-2.22M
62.01%-1.67M
62.94%-1.37M
45.08%-855.22K
-5.90%-4.65M
-155.71%-4.39M
-134.75%-3.7M
Research and development
32.02%71.04M
40.77%51.71M
-18.97%19.08M
8.03%91.78M
-10.22%53.81M
-14.17%36.73M
87.78%23.55M
15.11%84.96M
14.40%59.93M
37.26%42.8M
Credit Impairment Loss
46.68%-1.05M
24.62%-1.61M
-76.73%-1.4M
-77.85%-3.74M
48.83%-1.97M
63.04%-2.13M
49.93%-790.34K
-780.30%-2.11M
-137.21%-3.85M
-339.74%-5.76M
Asset Impairment Loss
-6.03%-9.6M
17.42%-7.89M
-27.91%-2.65M
-31.81%-12.13M
-64.63%-9.05M
-202.75%-9.55M
14.19%-2.07M
-143.32%-9.2M
-57.11%-5.5M
-21.54%-3.16M
Other net revenue
382.65%35.75M
15,510.68%28.7M
141.47%7.63M
-58.97%15.22M
-69.70%7.41M
-98.71%183.86K
189.80%3.16M
-1.14%37.09M
-28.66%24.45M
257.67%14.22M
Fair value change income
-92.99%87.46K
-90.27%141.88K
-103.73%-36.24K
407.47%1.6M
-47.78%1.25M
5.67%1.46M
25,297.63%972.79K
926.44%315.52K
188.05%2.39M
-43.16%1.38M
Invest income
206.13%27.63M
395.96%26.12M
-7.06%3.19M
-58.52%11.4M
-67.18%9.03M
-73.39%5.27M
1,038.88%3.43M
-14.88%27.49M
-10.12%27.5M
2,776.60%19.79M
-Including: Investment income associates
----
----
32.21%2.56M
639.45%7.83M
----
----
392.73%1.94M
126.44%1.06M
----
----
Asset deal income
-96.19%3.54K
-98.16%1.77K
----
--20.1K
--92.97K
2,621.34%96.4K
----
----
----
99.84%-3.82K
Other revenue
131.58%18.68M
136.40%11.93M
427.78%8.52M
-12.27%18.07M
106.33%8.07M
155.81%5.05M
91.41%1.61M
74.10%20.59M
-62.67%3.91M
-77.07%1.97M
Operating profit
4.21%137.1M
15.86%101.02M
52.02%44.11M
-30.37%177.73M
-31.24%131.56M
-40.69%87.2M
-62.76%29.02M
6.34%255.27M
-1.74%191.33M
31.22%147.02M
Add:Non operating Income
-52.44%216.97K
-71.82%111.34K
-35.23%153.68K
-65.20%1.09M
79.58%456.2K
107.19%395.08K
113.46%237.28K
641.47%3.15M
-29.88%254.04K
-15.45%190.69K
Less:Non operating expense
-34.72%456.77K
-60.57%255.28K
-61.18%94.74K
602.15%7.01M
3.21%699.74K
15.28%647.46K
25,623.96%244.05K
52.30%998.83K
44.83%678K
106.28%561.61K
Total profit
4.22%136.86M
16.03%100.88M
52.26%44.17M
-33.25%171.82M
-31.21%131.32M
-40.71%86.94M
-62.83%29.01M
7.34%257.42M
-1.90%190.91M
30.94%146.65M
Less:Income tax cost
-12.21%13.75M
-14.62%9.35M
215.04%4.89M
-17.84%19.34M
-13.35%15.66M
-29.44%10.95M
-86.94%1.55M
-23.03%23.53M
-24.87%18.08M
12.23%15.52M
Net profit
6.45%123.11M
20.45%91.53M
43.05%39.28M
-34.80%152.48M
-33.08%115.66M
-42.05%75.99M
-58.49%27.46M
11.77%233.88M
1.34%172.83M
33.57%131.13M
Net profit from continuing operation
6.45%123.11M
20.45%91.53M
43.05%39.28M
-34.80%152.48M
-33.08%115.66M
-42.05%75.99M
-58.49%27.46M
11.77%233.88M
1.34%172.83M
33.57%131.13M
Less:Minority Profit
165.32%2.17M
190.60%1.3M
135.15%1.03M
-212.58%-8.12M
-328.33%-3.32M
---1.44M
---2.92M
--7.21M
--1.46M
----
Net profit of parent company owners
1.65%120.94M
16.53%90.23M
25.94%38.25M
-29.15%160.6M
-30.57%118.98M
-40.95%77.43M
-54.08%30.37M
8.33%226.67M
0.48%171.38M
33.57%131.13M
Earning per share
Basic earning per share
1.59%0.64
17.50%0.47
25.00%0.2
-28.81%0.84
-30.77%0.63
-41.18%0.4
-60.98%0.16
-11.28%1.18
-16.51%0.91
9.68%0.68
Diluted earning per share
1.59%0.64
17.50%0.47
25.00%0.2
-28.81%0.84
-30.77%0.63
-41.18%0.4
-60.98%0.16
-11.28%1.18
-16.51%0.91
9.68%0.68
Other composite income
Total composite income
6.45%123.11M
20.45%91.53M
43.05%39.28M
-34.80%152.48M
-33.08%115.66M
-42.05%75.99M
-58.49%27.46M
11.77%233.88M
1.34%172.83M
33.57%131.13M
Total composite income of parent company owners
1.65%120.94M
16.53%90.23M
25.94%38.25M
-29.15%160.6M
-30.57%118.98M
-40.95%77.43M
-54.08%30.37M
8.33%226.67M
0.48%171.38M
33.57%131.13M
Total composite income of minority owners
165.32%2.17M
190.60%1.3M
135.15%1.03M
-212.58%-8.12M
-328.33%-3.32M
---1.44M
---2.92M
--7.21M
--1.46M
----
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Zhonghui Certified Public Accountants (Special General Partnership)
--
--
--
Zhonghui Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023
Total operating revenue -3.95%1.08B-4.80%732.44M7.98%360.23M-20.11%1.52B-26.20%1.13B-39.32%769.33M-58.90%333.62M-26.31%1.9B-19.52%1.52B3.14%1.27B
Operating revenue -3.95%1.08B-4.80%732.44M7.98%360.23M-20.11%1.52B-26.20%1.13B-39.32%769.33M-58.90%333.62M-26.31%1.9B-19.52%1.52B3.14%1.27B
Other operating revenue ----55.83%18.33M----112.79%30.32M----92.44%11.77M----60.75%14.25M----75.17%6.11M
Total operating cost -2.16%979.33M-3.25%660.11M5.19%323.75M-19.41%1.36B-26.27%1B-39.88%682.32M-57.86%307.76M-29.21%1.68B-21.69%1.36B1.23%1.13B
Operating cost 13.16%382.96M19.54%261.87M28.42%132.78M-49.22%468.29M-58.50%338.42M-69.65%219.06M-79.93%103.4M-42.90%922.2M-29.85%815.4M-3.32%721.72M
Operating tax surcharges 5.27%17.54M-8.39%10.69M14.46%5.5M22.34%22.43M30.15%16.66M16.91%11.67M-15.14%4.8M14.90%18.34M6.89%12.8M25.29%9.98M
Operating expense -13.24%458.55M-18.37%302.49M-4.83%150.76M15.65%692.13M23.87%528.54M11.67%370.54M-13.61%158.41M-2.91%598.45M-8.77%426.7M7.20%331.81M
Administration expense -23.51%48.88M-25.71%33.3M-12.14%15.86M31.64%81.56M37.25%63.91M44.25%44.82M19.01%18.05M4.76%61.96M17.64%46.56M20.82%31.07M
Financial expense 198.13%365.97K111.60%59.28K48.85%-225.56K93.13%-226.27K90.11%-372.94K78.70%-510.91K71.63%-440.98K7.13%-3.29M-916.36%-3.77M-1,082.64%-2.4M
-Interest expense (Financial expense) 16.98%1.08M68.35%1.4M14.75%264.36K49.89%1.92M73.96%926.62K-33.14%832.41K106.40%230.38K43.93%1.28M254.87%532.67K93.44%1.25M
-Interest Income (Financial expense) 22.91%-1.28M-3.35%-1.42M32.49%-577.33K52.22%-2.22M62.01%-1.67M62.94%-1.37M45.08%-855.22K-5.90%-4.65M-155.71%-4.39M-134.75%-3.7M
Research and development 32.02%71.04M40.77%51.71M-18.97%19.08M8.03%91.78M-10.22%53.81M-14.17%36.73M87.78%23.55M15.11%84.96M14.40%59.93M37.26%42.8M
Credit Impairment Loss 46.68%-1.05M24.62%-1.61M-76.73%-1.4M-77.85%-3.74M48.83%-1.97M63.04%-2.13M49.93%-790.34K-780.30%-2.11M-137.21%-3.85M-339.74%-5.76M
Asset Impairment Loss -6.03%-9.6M17.42%-7.89M-27.91%-2.65M-31.81%-12.13M-64.63%-9.05M-202.75%-9.55M14.19%-2.07M-143.32%-9.2M-57.11%-5.5M-21.54%-3.16M
Other net revenue 382.65%35.75M15,510.68%28.7M141.47%7.63M-58.97%15.22M-69.70%7.41M-98.71%183.86K189.80%3.16M-1.14%37.09M-28.66%24.45M257.67%14.22M
Fair value change income -92.99%87.46K-90.27%141.88K-103.73%-36.24K407.47%1.6M-47.78%1.25M5.67%1.46M25,297.63%972.79K926.44%315.52K188.05%2.39M-43.16%1.38M
Invest income 206.13%27.63M395.96%26.12M-7.06%3.19M-58.52%11.4M-67.18%9.03M-73.39%5.27M1,038.88%3.43M-14.88%27.49M-10.12%27.5M2,776.60%19.79M
-Including: Investment income associates --------32.21%2.56M639.45%7.83M--------392.73%1.94M126.44%1.06M--------
Asset deal income -96.19%3.54K-98.16%1.77K------20.1K--92.97K2,621.34%96.4K------------99.84%-3.82K
Other revenue 131.58%18.68M136.40%11.93M427.78%8.52M-12.27%18.07M106.33%8.07M155.81%5.05M91.41%1.61M74.10%20.59M-62.67%3.91M-77.07%1.97M
Operating profit 4.21%137.1M15.86%101.02M52.02%44.11M-30.37%177.73M-31.24%131.56M-40.69%87.2M-62.76%29.02M6.34%255.27M-1.74%191.33M31.22%147.02M
Add:Non operating Income -52.44%216.97K-71.82%111.34K-35.23%153.68K-65.20%1.09M79.58%456.2K107.19%395.08K113.46%237.28K641.47%3.15M-29.88%254.04K-15.45%190.69K
Less:Non operating expense -34.72%456.77K-60.57%255.28K-61.18%94.74K602.15%7.01M3.21%699.74K15.28%647.46K25,623.96%244.05K52.30%998.83K44.83%678K106.28%561.61K
Total profit 4.22%136.86M16.03%100.88M52.26%44.17M-33.25%171.82M-31.21%131.32M-40.71%86.94M-62.83%29.01M7.34%257.42M-1.90%190.91M30.94%146.65M
Less:Income tax cost -12.21%13.75M-14.62%9.35M215.04%4.89M-17.84%19.34M-13.35%15.66M-29.44%10.95M-86.94%1.55M-23.03%23.53M-24.87%18.08M12.23%15.52M
Net profit 6.45%123.11M20.45%91.53M43.05%39.28M-34.80%152.48M-33.08%115.66M-42.05%75.99M-58.49%27.46M11.77%233.88M1.34%172.83M33.57%131.13M
Net profit from continuing operation 6.45%123.11M20.45%91.53M43.05%39.28M-34.80%152.48M-33.08%115.66M-42.05%75.99M-58.49%27.46M11.77%233.88M1.34%172.83M33.57%131.13M
Less:Minority Profit 165.32%2.17M190.60%1.3M135.15%1.03M-212.58%-8.12M-328.33%-3.32M---1.44M---2.92M--7.21M--1.46M----
Net profit of parent company owners 1.65%120.94M16.53%90.23M25.94%38.25M-29.15%160.6M-30.57%118.98M-40.95%77.43M-54.08%30.37M8.33%226.67M0.48%171.38M33.57%131.13M
Earning per share
Basic earning per share 1.59%0.6417.50%0.4725.00%0.2-28.81%0.84-30.77%0.63-41.18%0.4-60.98%0.16-11.28%1.18-16.51%0.919.68%0.68
Diluted earning per share 1.59%0.6417.50%0.4725.00%0.2-28.81%0.84-30.77%0.63-41.18%0.4-60.98%0.16-11.28%1.18-16.51%0.919.68%0.68
Other composite income
Total composite income 6.45%123.11M20.45%91.53M43.05%39.28M-34.80%152.48M-33.08%115.66M-42.05%75.99M-58.49%27.46M11.77%233.88M1.34%172.83M33.57%131.13M
Total composite income of parent company owners 1.65%120.94M16.53%90.23M25.94%38.25M-29.15%160.6M-30.57%118.98M-40.95%77.43M-54.08%30.37M8.33%226.67M0.48%171.38M33.57%131.13M
Total composite income of minority owners 165.32%2.17M190.60%1.3M135.15%1.03M-212.58%-8.12M-328.33%-3.32M---1.44M---2.92M--7.21M--1.46M----
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Zhonghui Certified Public Accountants (Special General Partnership)------Zhonghui Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More